Global malaria community calls for increased investment in development and scale-up of malaria innovations following R21 vaccine announcement – but RBM Partnership warns “it’s not the only solution”.

Basic childhood immunisation rebounded in 2022, as lower-income countries committed historic levels of domestic funding to immunisation programmes.

Efforts to vaccinate “zero-dose” children in the Democratic Republic of the Congo (DRC) will be accelerated thanks to new funding from Gavi, the Vaccine Alliance’s Equity Accelerator Fund (EAF).

The WHO’s chief advisory group on immunisation has recommended the new R21/Matrix-M malaria vaccine.

You’ll never look at bagged lettuce the same way again.

When outbreaks of the deadly bacterial zoonosis crop up, it takes a multi-sectoral effort to prevent cross-species spread.